MedPath

Evaluating the effectiveness of bariatric surgeries: Scopinaro modified and classic Scopinaro in treating obesity

Phase 2
Conditions
obesity
C18.654.726.500
Registration Number
RBR-842vr3
Lead Sponsor
Instituto Paulo Reis de Clínica Cirúrgica e Obesidade Mórbida S/S
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

28 participants.Individuals of both sexes. Age between 18 and 65 years. Body Mass Index (BMI)more than 35. Body Mass Index greater than or equal to 40. Be indicated for bariatric surgery after other attempts at treatment. If BMI more than 35 and less than 40 must submit AT LEAST one comorbidity (Type II diabetes or dyslipidemia or hypertension or joint arthropathy in average or great or sleep apnea or hypothyroidism).

Exclusion Criteria

Pregnant or breastfeeding.Undergone bariatric surgery révia.Apresentar limiting psychiatric disorders according to the evaluation of especialista.Be user of illegal drugs or alcohol abuse. Be severe disease carrier according to an evaluation specialist. Be severe lung disease carrier according to the evaluation of especialista.Ser of liver cirrhosis carrier. Being active virus carrier(HIV). Has any condition that prevents surgery

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the nutritional status of the participant, evaluated by blood test for evaluation of protein, blood count and periodic evaluations with the doctor. First results after 180 days after the procedure.
Secondary Outcome Measures
NameTimeMethod
Worsening of pre-existing diseases, reported in the preoperative period, evaluated by blood tests and medical appointments.;Increase the participant's weight loss without enough of it. Reviewed medical consultation, evaluating the body mass index.
© Copyright 2025. All Rights Reserved by MedPath